NEWS: Chlorpheniramine Naloxone Oxazepam Prednisolone Plendil Insulin. Neomycin Amoxil Furazolidone Thiotepa Dilantin Plendil! Amitriptyline Trandolapril Risperdal Benadryl Naproxen Dulcolax Beclomethasone Morphine Quinidine Aldara Dolasetron Ethanol Acetylcholine Phenacetin! Fenoterol Avalide Diethylpropion Cytomel, Elocon Tolazamide Disopyramide Glimepiride Cycloserine Chlordiazepoxide: Naloxone Cephalothin. Benicar Dextroamphetamine Hexoprenaline Levitra Podofilox Midodrine: Cyproheptadine Isradipine Fenoprofen Cefamandole, Darvocet Granisetron Cefatrizine Estrone Pyridostigmine Butalbital Belladonna Phenylephrine Levlen Trovafloxacin Avodart Warfarin Ethinyl Gemfibrozil. Mephentermine Cefprozil Nylidrin Diphenoxylate Xanax Methantheline Adipex Ibuprofen? Carbachol Dyphylline Chlordiazepoxide Dantrolene? Vytorin Ceftriaxone Phencyclidine Indinavir? Paregoric Demerol Levothyroxine Ceftibuten Iodoquinol Cycrimine Buclizine Mefloquine, Danazol Colace Zoloft Primidone: Viagra Piroxicam Cardizem Cloxacillin Promazine Paromomycin Pilocarpine Butorphanol Pravastatin Toprol Epoprostenol Promazine Digitalis Nizoral Foradil Oxycontin Hydroflumethiazide Enoxaparin Dilaudid Piperidolate Singulair Tretinoin Thiothixene Propylthiouracil Bethanechol Erythrityl Fentanyl Prochlorperazine! Lopressor Dimethindene. Isopropamide Cholestyramine! Demeclocycline Piperacillin Amikacin Prometrium Zileuton Lozol Nitrofurantoin Moxalactam Trimethoprim Sinemet Corticotropin Carbenicillin: Esomeprazole Miconazole Doxepin Hydromorphone Hydromorphone Desyrel! Probucol Echothiophate Ethchlorvynol Hydroxychloroquine! Hydrochlorothiazide Prozac Trimetrexate Somatostatin Adapalene Doxorubicin? Disulfiram Streptomycin Pheniramine Lunesta Ergocalciferol Pargyline Bleomycin Maprotiline Pantothenic Terbinafine Penicillin Acarbose Cerivastatin Amaryl Guanabenz Climara: Mestranol Aminopterin Clotrimazole Chantix Trientine Amantadine Cocaine Heroin Aprotinin Carteolol Mifepristone Oxytetracycline. Naratriptan Xanax: Cosopt Metoprolol, Clomocycline Flagyl Phensuximide Cortisol Botox Acebutolol Ditropan Chlortetracycline Diovan Nialamide! Betamethasone Chlorothiazide Suboxone Ketoprofen Protonix Lotrel! Methamphetamine Dichlorphenamide Perindopril Isocarboxazid: Iodine Prednisone Augmentin Sildenafil! Tacrolimus Tolmetin! Ethinamate Dalteparin Pseudoephedrine Thiabendazole Acarbose Vytorin Norvasc Diethylstilbestrol Nafcillin Acyclovir. Protriptyline Yohimbine Daunorubicin Guaifenesin Sulfasalazine Celiprolol Amoxapine Bricanyl Gatifloxacin Oxybutynin Diethylstilbestrol Demecarium Medrol Concerta Methacycline Vincristine Butorphanol Mucomyst Digoxin Dioxyline Trileptal Methoxsalen Acebutolol Casanthranol: Pediacare Ergocalciferol:

Customer Financing

 

Many companies offer to sell products to their customers on credit. When a company sells products on credit it records the full value of the sale as revenues immediately. In addition, it may earn future interest income as the loan is paid off. Although the practice is common and legitimate, it also can frequently be a source of trouble for the lending company. Analysts and investors should always be on the alert for potential problems when considering a company that offers financing to its customers.

The first potential issue is that the customer is unable to repay and the company does not actually receive the cash it has already booked as revenue. To guard against this risk, companies do not book all of the revenue up front, but rather reserve some of it as an allowance for potential bad debts. We have discussed in the past these issues, particularly as they relate to Xerox. To spot potential trouble investors can look for changes in the allowance for doubtful account relative to the level of financial receivables and sales.

The second issue is that companies (or their commissioned salespeople) may have an incentive to make sales to customers with questionable credit quality. During the telecom boom in the late 1990’s, Lucent and Nortel sold an enormous amount of equipment to startup companies that ended up going bankrupt. Although the equipment makers were able to take back the equipment, there were no other buyers for it. Investors should look out for this when financial receivables are growing at a faster rate than overall sales, as it may be a sign that the company has targeted lower credit quality customers.

Similarly, companies may temporarily offer enticing financing arrangements in order to boost sales levels in a given quarter to meet earnings or sales targets. Management bonuses may be significantly impacted by such short-term factors. This is harder for investors to spot. Some management compensation disclosures, found in proxy statements or 8k reports, may be useful for determining target sales levels. This is also an area where Peter Lynch’s “invest in what you know” philosophy can pay off. Industry insiders are more likely to know when their own company or a competitor is issuing short-term incentives to boost sales.

For more information, see all articles on: Financial Statement Analysis, Fundamental Analysis, Investing in Stocks

See also:
  • Listing Stocks on Multiple Worldwide Exchanges
  • How Lessors Report Capital Leases Classified as Direct Financing
  • The Weighted Average Cost of Capital
  • Cash Flows from Financing Activities
  • Interest and Dividends: Differences Between US GAAP and International Accounting Standards
  • Technical Analysis Explained : The Successful Investor's Guide to Spotting Investment Trends and Turning Points

    The Intelligent Investor: The Classic Text on Value Investing

    Financial Statement Analysis: A Practitioner's Guide, 3rd Edition

    Managing Investment Portfolios: A Dynamic Process (CFA Institute Investment Series)

    Leave a Reply

    You must be logged in to post a comment.

    ss_blog_claim=03ab3ad958d87eac8403bc8f2fe29a6d